R-ABVD vs ABVD-RT in Early Stage Hodgkin's Lymphoma
NCT00992030
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
112
Enrollment
OTHER
Sponsor class
Stopped
Low recruitment and difficulty in having study data
Conditions
Hodgkin Lymphoma
Interventions
DRUG:
Rituximab
RADIATION:
Involved field irradiation
Sponsor
Fondazione Michelangelo